JPWO2021132591A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021132591A5 JPWO2021132591A5 JP2021567687A JP2021567687A JPWO2021132591A5 JP WO2021132591 A5 JPWO2021132591 A5 JP WO2021132591A5 JP 2021567687 A JP2021567687 A JP 2021567687A JP 2021567687 A JP2021567687 A JP 2021567687A JP WO2021132591 A5 JPWO2021132591 A5 JP WO2021132591A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
- 本明細書に記載された発明。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022097020A JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン50のスキッピングを誘導するアンチセンス核酸 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019236704 | 2019-12-26 | ||
PCT/JP2020/048803 WO2021132591A1 (ja) | 2019-12-26 | 2020-12-25 | エクソン50のスキッピングを誘導するアンチセンス核酸 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022097020A Division JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン50のスキッピングを誘導するアンチセンス核酸 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2021132591A1 JPWO2021132591A1 (ja) | 2021-07-01 |
JPWO2021132591A5 true JPWO2021132591A5 (ja) | 2024-01-09 |
Family
ID=76574765
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021567687A Pending JPWO2021132591A1 (ja) | 2019-12-26 | 2020-12-25 | |
JP2022097020A Active JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン50のスキッピングを誘導するアンチセンス核酸 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022097020A Active JP7201192B2 (ja) | 2019-12-26 | 2022-06-16 | エクソン50のスキッピングを誘導するアンチセンス核酸 |
Country Status (14)
Country | Link |
---|---|
US (2) | US20230073008A1 (ja) |
EP (1) | EP4083208A4 (ja) |
JP (2) | JPWO2021132591A1 (ja) |
KR (1) | KR20220122673A (ja) |
CN (1) | CN114901823A (ja) |
AU (1) | AU2020411964A1 (ja) |
BR (1) | BR112022012622A2 (ja) |
CA (1) | CA3165961A1 (ja) |
CO (1) | CO2022008664A2 (ja) |
IL (1) | IL294271A (ja) |
MX (1) | MX2022007937A (ja) |
TW (1) | TW202138560A (ja) |
WO (1) | WO2021132591A1 (ja) |
ZA (1) | ZA202206667B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023168427A1 (en) | 2022-03-03 | 2023-09-07 | Yale University | Compositions and methods for delivering therapeutic polynucleotides for exon skipping |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
EP0506830B1 (en) | 1989-12-20 | 2005-12-14 | Avi Biopharma, Inc. | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
JP2924179B2 (ja) | 1993-02-19 | 1999-07-26 | 日本新薬株式会社 | グリセロール誘導体,デバイス及び医薬組成物 |
IL115849A0 (en) | 1994-11-03 | 1996-01-31 | Merz & Co Gmbh & Co | Tangential filtration preparation of liposomal drugs and liposome product thereof |
ES2566628T3 (es) | 2002-11-25 | 2016-04-14 | Masafumi Matsuo | Fármacos de ácido nucleico ENA que modifican el corte y empalme en precursores de ARNm |
EP4047096A1 (en) | 2004-06-28 | 2022-08-24 | The University Of Western Australia | Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
LT2024499T (lt) | 2006-05-10 | 2018-02-26 | Sarepta Therapeutics, Inc. | Oligonukleotido analogai, turintys katijonines jungtis tarp subvienetų |
ES2694726T3 (es) | 2007-06-29 | 2018-12-26 | Sarepta Therapeutics, Inc. | Conjugados peptídicos específicos de tejido y métodos |
MX2010004955A (es) | 2007-11-15 | 2010-06-30 | Avi Biopharma Inc | Metodo de sintesis de oligomeros de morfolina. |
EP3428278A1 (en) * | 2008-10-24 | 2019-01-16 | Sarepta Therapeutics, Inc. | Multiple exon skipping compositions for dmd |
PT2607484E (pt) | 2008-10-27 | 2016-03-09 | Academisch Ziekenhuis Leiden | Métodos e meios para o salto eficiente do exão 45 no pré-mrna de distrofia muscular de duchenne |
CN101388842B (zh) | 2008-10-30 | 2012-04-04 | 华为技术有限公司 | 一种存储方法和装置 |
CN103003430A (zh) | 2009-11-12 | 2013-03-27 | 西澳大利亚大学 | 反义分子和治疗疾病的方法 |
TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
JP6478632B2 (ja) | 2011-05-05 | 2019-03-06 | サレプタ セラピューティクス, インコーポレイテッド | ペプチドオリゴヌクレオチドコンジュゲート |
JP2013100190A (ja) | 2011-11-07 | 2013-05-23 | Fumihiro Mitamura | コンクリート組成物の製造方法 |
CN117721110A (zh) | 2011-12-28 | 2024-03-19 | 日本新药株式会社 | 反义核酸 |
NZ631289A (en) * | 2013-03-15 | 2017-08-25 | Sarepta Therapeutics Inc | Improved compositions for treating muscular dystrophy |
KR20240035901A (ko) | 2015-05-19 | 2024-03-18 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 펩티드 올리고뉴클레오티드 콘주게이트 |
SI3331891T1 (sl) | 2015-08-05 | 2022-04-29 | Eisai R&D Management Co., Ltd. | Postopek priprave v bistvu diastereomerno čistega fosforodiamidatnega oligomera, fosforodiamidatni oligomer izdelan po takem postopku in farmacevtski sestavek, ki vsebuje tak fosforodiamidatni oligomer |
EP3359523A4 (en) | 2015-10-09 | 2019-07-24 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND RELATED METHODS |
EP3359668A4 (en) * | 2015-10-09 | 2019-06-05 | Sarepta Therapeutics, Inc. | COMPOSITIONS AND METHODS OF TREATING DUCHENNE MUSCLE DYSTROPHY AND ASSOCIATED ILLNESSES THEREOF |
WO2018014042A1 (en) * | 2016-07-15 | 2018-01-18 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulation of dystrophin transcript |
WO2018118599A1 (en) | 2016-12-19 | 2018-06-28 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
CA3047010A1 (en) | 2016-12-19 | 2018-06-28 | Sarepta Therapeutics, Inc. | Exon skipping oligomer conjugates for muscular dystrophy |
LT3554554T (lt) | 2016-12-19 | 2022-11-25 | Sarepta Therapeutics, Inc. | Egzoną praleidžiantys oligomero konjugatai nuo raumenų distrofijos |
BR112021011018A2 (pt) | 2018-12-13 | 2021-08-31 | Sarepta Therapeutics, Inc. | Conjugados de oligômero para exon skipping para distrofia muscular |
-
2020
- 2020-12-25 IL IL294271A patent/IL294271A/en unknown
- 2020-12-25 AU AU2020411964A patent/AU2020411964A1/en active Pending
- 2020-12-25 CN CN202080090310.0A patent/CN114901823A/zh active Pending
- 2020-12-25 CA CA3165961A patent/CA3165961A1/en active Pending
- 2020-12-25 KR KR1020227024957A patent/KR20220122673A/ko active Search and Examination
- 2020-12-25 EP EP20906005.2A patent/EP4083208A4/en active Pending
- 2020-12-25 US US17/788,826 patent/US20230073008A1/en active Pending
- 2020-12-25 TW TW109146242A patent/TW202138560A/zh unknown
- 2020-12-25 MX MX2022007937A patent/MX2022007937A/es unknown
- 2020-12-25 WO PCT/JP2020/048803 patent/WO2021132591A1/ja active Application Filing
- 2020-12-25 BR BR112022012622A patent/BR112022012622A2/pt unknown
- 2020-12-25 JP JP2021567687A patent/JPWO2021132591A1/ja active Pending
-
2022
- 2022-06-15 ZA ZA2022/06667A patent/ZA202206667B/en unknown
- 2022-06-16 JP JP2022097020A patent/JP7201192B2/ja active Active
- 2022-06-22 CO CONC2022/0008664A patent/CO2022008664A2/es unknown
- 2022-06-23 US US17/847,333 patent/US11655472B2/en active Active